The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alwan, W. H.
Right arrow Articles by Openshaw, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alwan, W. H.
Right arrow Articles by Openshaw, P. J.

The Journal of Immunology, Vol 150, Issue 12 5211-5218, Copyright © 1993 by American Association of Immunologists


ARTICLES

Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins

WH Alwan, FM Record and PJ Openshaw
Department of Medicine, St. Mary's Hospital Medical School, London, United Kingdom.

Mice sensitized to individual respiratory syncytial (RS) virus proteins show distinct patterns of immunity and pulmonary pathology when challenged with live virus. To explore the immune mechanisms responsible for the differences in postvaccination disease, BALB/c (H- 2d) mice were primed by scarification with recombinant vaccinia viruses (rVV) expressing the major glycoprotein (G), fusion protein (F), phosphoprotein (P), nucleoprotein (N), or second matrix (22K) protein of RS virus. Ag-stimulated spleen cell cultures gave rise to CD3+TCR- alpha beta + T cell lines. Those from rVV-F-primed mice contained a mixture of CD8+ and CD4+ T cells, whereas those specific to G, N, and P were mostly CD4+. In contrast, 22K-specific lines were mostly CD8+. F- and 22K-specific lines showed virus-specific CTL activity against H-2d targets, but the lines from rVV-G-, -N-, and -P-primed mice did not. The F-specific lines contained Th cells that released an excess of IL-2 and some IL-3 but little IL-4 or IL-5 (i.e., a "Th1" pattern). In contrast, the G-specific line released IL-3, IL-4, and IL-5 but little IL-2 (i.e., a "Th2" pattern). The 22K line contained IL-3-releasing T cells. Staining of T cell subsets for CD45RB varied in intensity in different lines, consistent with the cytokine secretion profiles of the Th cells that they contained. Because different RS virus proteins (given in the same form by the same route) prime for functionally different T cells, the ways in which individual proteins are processed and presented might be important in determining these patterns of immunity.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
P. T. Morrison, L. H. Thomas, M. Sharland, and J. S. Friedland
RSV-infected airway epithelial cells cause biphasic up-regulation of CCR1 expression on human monocytes
J. Leukoc. Biol., June 1, 2007; 81(6): 1487 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. W. Lukacs, M. L. Moore, B. D. Rudd, A. A. Berlin, R. D. Collins, S. J. Olson, S. B. Ho, and R. S. Peebles Jr
Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial Virus
Am. J. Pathol., September 1, 2006; 169(3): 977 - 986.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. A. Tripp, C. Oshansky, and R. Alvarez
Cytokines and Respiratory Syncytial Virus Infection
Proceedings of the ATS, August 1, 2005; 2(2): 147 - 149.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C Schneider, T Schmidt, C Ziske, K Tiemann, K-M Lee, V Uhlinsky, P Behrens, T Sauerbruch, I G H Schmidt-Wolf, P F Muhlradt, et al.
Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model
Gut, March 1, 2004; 53(3): 355 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. M. van Bleek, M. C. Poelen, R. van der Most, H. F. Brugghe, H. A. M. Timmermans, C. J. Boog, P. Hoogerhout, H. G. Otten, and C. A. C. M. van Els
Identification of Immunodominant Epitopes Derived from the Respiratory Syncytial Virus Fusion Protein That Are Recognized by Human CD4 T Cells
J. Virol., December 20, 2002; 77(2): 980 - 988.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Werling, R. A. Collins, G. Taylor, and C. J. Howard
Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus
J. Leukoc. Biol., August 1, 2002; 72(2): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Kakimi, M. Isogawa, J. Chung, A. Sette, and F. V. Chisari
Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections
J. Virol., July 29, 2002; 76(17): 8609 - 8620.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Jiang, N. J. Borthwick, P. Morrison, G. F. Gao, and M. W. Steward
Virus-specific CTL responses induced by an H-2Kd-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus
J. Gen. Virol., February 1, 2002; 83(2): 429 - 438.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Wennergren and S. Kristjansson
Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Eur. Respir. J., December 1, 2001; 18(6): 1044 - 1058.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Hurst, B. W. P. Seymour, T. Muchamuel, V. P. Kurup, and R. L. Coffman
Modulation of Inhaled Antigen-Induced IgE Tolerance by Ongoing Th2 Responses in the Lung
J. Immunol., April 15, 2001; 166(8): 4922 - 4930.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. K. Tekkanat, H. F. Maassab, D. S. Cho, J. J. Lai, A. John, A. Berlin, M. H. Kaplan, and N. W. Lukacs
IL-13-Induced Airway Hyperreactivity During Respiratory Syncytial Virus Infection Is STAT6 Dependent
J. Immunol., March 1, 2001; 166(5): 3542 - 3548.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Walzl, S. Tafuro, P. Moss, P. J.M. Openshaw, and T. Hussell
Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus-induced Immunopathology
J. Exp. Med., November 6, 2000; 192(9): 1317 - 1326.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
G. P. Bembridge, N. Rodriguez, R. Garcia-Beato, C. Nicolson, J. A. Melero, and G. Taylor
DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation
J. Gen. Virol., October 1, 2000; 81(10): 2519 - 2523.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. D. MARTINEZ
Viruses and Atopic Sensitization in the First Years of Life
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): S95 - 99.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. L. L. KIMPEN
Viral Infections and Childhood Asthma
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): S108 - 112.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. BONT, C. J. HEIJNEN, A. KAVELAARS, W. M. C. van AALDEREN, F. BRUS, J. Th. M. DRAAISMA, S. M. GEELEN, and J. L. L. KIMPEN
Monocyte IL-10 Production during Respiratory Syncytial Virus Bronchiolitis Is Associated with Recurrent Wheezing in a One-Year Follow-up Study
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1518 - 1523.
[Abstract] [Full Text]


Home page
J. Virol.Home page
G. P. Bembridge, J. A. Lopez, R. Bustos, J. A. Melero, R. Cook, H. Mason, and G. Taylor
Priming with a Secreted Form of the Fusion Protein of Respiratory Syncytial Virus (RSV) Promotes Interleukin-4 (IL-4) and IL-5 Production but Not Pulmonary Eosinophilia following RSV Challenge
J. Virol., December 1, 1999; 73(12): 10086 - 10094.
[Abstract] [Full Text]


Home page
J. Virol.Home page
T. R. Johnson and B. S. Graham
Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism
J. Virol., October 1, 1999; 73(10): 8485 - 8495.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. A. Tripp, D. Moore, L. Jones, W. Sullender, J. Winter, and L. J. Anderson
Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice
J. Virol., September 1, 1999; 73(9): 7099 - 7107.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. Srikiatkhachorn, W. Chang, and T. J. Braciale
Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent
J. Virol., August 1, 1999; 73(8): 6590 - 6597.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. Schwarze, G. Cieslewicz, A. Joetham, T. Ikemura, E. Hamelmann, and E. W. Gelfand
CD8 T Cells Are Essential in the Development of Respiratory Syncytial Virus-Induced Lung Eosinophilia and Airway Hyperresponsiveness
J. Immunol., April 1, 1999; 162(7): 4207 - 4211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Hussell, A. Georgiou, T. E. Sparer, S. Matthews, P. Pala, and P. J. M. Openshaw
Host Genetic Determinants of Vaccine-Induced Eosinophilia During Respiratory Syncytial Virus Infection
J. Immunol., December 1, 1998; 161(11): 6215 - 6222.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Thomas, J. S. Friedland, M. Sharland, and S. Becker
Respiratory Syncytial Virus-Induced RANTES Production from Human Bronchial Epithelial Cells Is Dependent on Nuclear Factor-{kappa}B Nuclear Binding and Is Inhibited by Adenovirus-Mediated Expression of Inhibitor of {kappa}B{alpha}
J. Immunol., July 15, 1998; 161(2): 1007 - 1016.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. E. Sparer, S. Matthews, T. Hussell, A. J. Rae, B. Garcia-Barreno, J. A. Melero, and P. J.M. Openshaw
Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia
J. Exp. Med., June 1, 1998; 187(11): 1921 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. FOLKERTS, W. W. BUSSE, F. P. NIJKAMP, R. SORKNESS, and J. E. GERN
Virus-induced Airway Hyperresponsiveness and Asthma
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1708 - 1720.
[Full Text] [PDF]


Home page
J. Virol.Home page
G. P. Bembridge, J. A. Lopez, R. Cook, J. A. Melero, and G. Taylor
Recombinant Vaccinia Virus Coexpressing the F Protein of Respiratory Syncytial Virus (RSV) and Interleukin-4 (IL-4) Does Not Inhibit the Development of RSV-Specific Memory Cytotoxic T Lymphocytes, whereas Priming Is Diminished in the Presence of High Levels of IL-2 or Gamma Interferon
J. Virol., May 1, 1998; 72(5): 4080 - 4087.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. R. Johnson, J. E. Johnson, S. R. Roberts, G. W. Wertz, R. A. Parker, and B. S. Graham
Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge
J. Virol., April 1, 1998; 72(4): 2871 - 2880.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Srikiatkhachorn and T. J. Braciale
Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection
J. Exp. Med., August 4, 1997; 186(3): 421 - 432.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. ROMN, W. J. CALHOUN, K. L. HINTON, L. F. AVENDAO, V. SIMON, A. M. ESCOBAR, A. GAGGERO, and P. V. DAZ
Respiratory Syncytial Virus Infection in Infants Is Associated with Predominant Th-2-like Response
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 190 - 195.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.